Home > Publications . Search All . Browse All . Country . Browse PSC Pubs . PSC Report Series

PSC In The News

RSS Feed icon

ISR's Scott Page says diverse teams produce optimal results

Bound, Geronimus, et al. find estimates of decreasing longevity among low-SES whites sensitive to measures and interpretations

Thompson casts doubt on the rehabilitative intentions of prison labor

More News

Highlights

Seefeldt discusses her book Abandoned Families, Wed, March 29, 4 PM, Annenberg Auditorium

U-M participants at PAA Annual Meeting, April 27-29

Heather Ann Thompson wins Bancroft Prize for History for 'Blood in the Water'

Michigan ranks in USN&WR top-10 grad schools for sociology, public health, labor economics, social policy, social psychology

More Highlights

Next Brown Bag

Mon, April 10, 2017, noon:
Elizabeth Bruch

Type 2 diabetes mellitus and the risk of sudden cardiac arrest in the community

Publication Abstract

Siscovick, D.S., N. Sotoodehnia, T.D. Rea, Trivellore Raghunathan, X. Jouven, and R.N. Lemaitre. 2010. "Type 2 diabetes mellitus and the risk of sudden cardiac arrest in the community." Reviews in Endocrine and Metabolic Disorders, 11(1): 53-59.

The reduction of mortality from sudden cardiac arrest (SCA) in the setting of coronary heart disease (CHD) remains a major challenge, especially among patients with type 2 diabetes. Diabetes is associated with an increased risk of SCA, at least in part, from an increased presence and extent of coronary atherosclerosis (macrovascular disease). Diabetes also is associated with microvascular disease and autonomic neuropathy; and, these non-coronary atherosclerotic pathophysiologic processes also have the potential to increase the risk of SCA. In this report, we review the absolute and relative risk of SCA associated with diabetes. We summarize recent evidence that suggests that the increase in risk in patients with diabetes is not specific for SCA, as diabetes also is associated with a similar increase in risk for non-SCA CHD death and non-fatal myocardial infarction. These data are consistent with prior observations that coronary atherosclerosis is a major contributor to the increased SCA risk associated with diabetes. We also present previously published and unpublished data that demonstrates that both clinically-recognized microvascular and autonomic neuropathy also are associated with the risk of SCA among treated patients with diabetes, after taking into account prior clinically-recognized heart disease and other risk factors for SCA. We then discuss how these data might inform research and clinical efforts to prevent SCA. Although the prediction of SCA in this "high" risk population is likely to remain a challenge, as it is in other "high" risk clinical populations, we suggest that current recommendations for the prevention of SCA in the community, related to both lifestyle prescriptions and risk factor reduction, are likely to reduce mortality from SCA among patients with diabetes.

DOI:10.1007/s11154-010-9133-5 (Full Text)

PMCID: PMC3413310. (Pub Med Central)

Country of focus: United States of America.

Browse | Search : All Pubs | Next